eFoodSafety's OraPhyte™ Patent Granted by U.S. Patent and Trademark Office

Business Wire, June 26, 2008

Positive Results of the Company's Product Lead to Continued Testing Through Several Major Universities

SCOTTSDALE, Ariz. -- eFoodSafety.com, Inc. (OTCBB: EFSF, www.efoodsafety.com), a researcher, developer, and marketer of whole foods and nutraceutical products, through its wholly-owned subsidiary Knock-Out Technologies, Ltd., has received approval from the U.S. Patent and Trademark Office for the issuance of a patent for the Company's OraPhyte[TM] disinfectant, filed September 22, 2006.

OraPhyte[TM] is an environmentally friendly product that is highly effective at killing microorganisms, including bacteria, molds, fungi, and viruses. U.S. Department of Agriculture tests have shown OraPhyte[TM] to be effective at eradicating nematodes, a parasite known to be harmful to plants, commonly found in freshwater, marine, and terrestrial environments. Crop damage attributable to nematodes accounts for significant economic losses in the multi-million dollar range.

To date, three major U.S. universities have conducted year-long agricultural studies of OraPhyte[TM], all of which resulted in the positive treatment of nematodes that affect plants or food crops. Based on the positive outcomes, these universities plan to continue testing. Additionally, a fourth major university will begin testing the product in its agricultural department undergoing crop-specific research. The additional testing will serve to refine the product and further identify specific uses in an effort to obtain a use-specific licensing agreement(s).

"The issuance of this patent is a monumental step towards the ultimate marketing of OraPhyte[TM] and serves to protect the intellectual property and formulation of the product," stated Robert Bowker, President of Knock-Out Technologies, Ltd., and formulator of OraPhyte[TM]. "This patent protection, coupled with the anticipated test results from participating universities, represents an important milestone for eFoodSafety as the Company moves towards licensing OraPhyte[TM]."

About eFoodSafety.com

eFoodSafety.com, Inc., based in Scottsdale, Arizona, is dedicated to improving health conditions around the world through its innovative technologies. Among eFoodSafety products currently available:

Citroxin[TM]: an environmentally safe product formulated entirely of food-grade components that kills six major bacteria as well as avian influenza.

Cinnergen[TM]: a clinically researched, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism.

Cinnechol[TM]: a multi-faceted nutritional supplement specifically designed to naturally promote healthy cholesterol and triglyceride levels without causing any negative side effects, as well as enhance overall cardiovascular health.

PurEffect[TM]: an anti-acne skin care system.

Immune Boost Bar[TM]: a non-dairy, no refined sugar, all-natural and comprehensive multi-nutrient product that helps fortify the body's immune system and is available in four delicious flavors: chocolate, oatmeal-raisin, chocolate mint and peanut butter.

Talsyn[TM]: a product that has been clinically proven to facilitate and improve the appearance, redness and strength of scars.

Please visit the company's website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.